Target intelligence / Profile preview

Coccidioides immitis antigens

Molecular classification
Other
01

Overview

Coccidioides immitis antigens are immunogenic components derived from the dimorphic fungal pathogen Coccidioides immitis, responsible for coccidioidomycosis (Valley Fever), including key proteins like the 19-kDa CS-Ag serine proteinase from the saprobic phase and SOWgp glycoproteins (58-82 kDa) from parasitic spherules. These antigens elicit both humoral and cellular immune responses, particularly T-cell mediated delayed-type hypersensitivity, where they are presented by MHC class I/II molecules to CD4+ and CD8+ T cells, triggering cytokine release and immune activation essential for controlling infection. In disease, they play roles in host-pathogen interaction, with high antibody titers or T-cell reactivity used for diagnosis via serology, PCR, or skin testing. Specific antigens like Ag2 are major T-cell-reactive wall components, while molecular markers based on genes such as csa, SOWgp82, and Ag2/PRA enable sensitive detection. Therapeutically, they are exploited in diagnostic skin tests like Coccidioides immitis spherule antigen rather than as direct drug targets, aiding in hypersensitivity detection for infection assessment. Challenges include genetic variability among isolates potentially affecting diagnostic accuracy and the need for validation across regions.

Other names
Coccidioides-specific antigen (CS-Ag)SOWgp (spherule outer wall glycoprotein)Ag2 (antigen 2)19-kDa serine proteinase antigen
02

Mechanism of action

Delayed-type hypersensitivity reaction via presentation to CD4/CD8 T cells, leading to cytokine secretion, vascular permeability, and induration

03

Biological functions

Immune responseAntigen presentation
04

Disease associations

Infection
05

Safety considerations

Risk of inducing hypersensitivity in sensitized individualsPotential for false negatives in mild disease
06

Interacting drugs

Coccidioides immitis spherule (skin test antigen, DB11294)
07

Biomarkers

Coccidioides galactomannan antigen (urine, for extensive disease)Sona Coccidioides Antibody LFA (total antibodies)EIA antigens for serology

Beyond the preview

Go deeper on Coccidioides immitis antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coccidioides immitis antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call